ArticleSignal transduction and targeted therapy2025

Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasis.

Ke-Yu Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.